The University of Chicago Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Hanauer, Stephen
One or more keywords matched the following items that are connected to Hanauer, Stephen
Item TypeName
Concept Antibodies, Monoclonal
Concept Antibodies, Antineutrophil Cytoplasmic
Concept Antibodies, Monoclonal, Humanized
Concept Antibodies
Concept Antibodies, Antinuclear
Academic Article Preliminary evaluation of safety and activity of recombinant human interleukin 11 in patients with active Crohn's disease.
Academic Article A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.
Academic Article Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety.
Academic Article An engineered human antibody to TNF (CDP571) for active Crohn's disease: a randomized double-blind placebo-controlled trial.
Academic Article Advances in the management of Crohn's disease: economic and clinical potential of infliximab.
Academic Article Infliximab for the treatment of fistulas in patients with Crohn's disease.
Academic Article Infliximab in Crohn's disease: first anniversary clinical experience.
Academic Article Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial.
Academic Article Updating the approach to Crohn's disease.
Academic Article Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease.
Academic Article Biologics in peri-operative management of Crohn's disease.
Academic Article Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot study.
Academic Article Evolutionary biologic therapy for inflammatory bowel disease.
Academic Article Immunogenicity of infliximab in Crohn's disease.
Academic Article Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial.
Academic Article Infliximab in the treatment of Crohn's disease: a user's guide for clinicians.
Academic Article Considerations in the management of steroid-dependent Crohn's disease.
Academic Article Remission in patients with Crohn's disease is associated with improvement in employment and quality of life and a decrease in hospitalizations and surgeries.
Academic Article Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease.
Academic Article Treatment of inflammatory bowel disease: safety and tolerability issues.
Academic Article Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohn's disease.
Academic Article A lupus-like syndrome associated with infliximab therapy.
Academic Article An open-label study of the human anti-TNF monoclonal antibody adalimumab in subjects with prior loss of response or intolerance to infliximab for Crohn's disease.
Academic Article Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: overview of randomized clinical studies.
Academic Article American gastroenterological association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease, June 21-23, 2006.
Academic Article Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial.
Academic Article Natalizumab induction and maintenance therapy for Crohn's disease.
Academic Article Emerging biologic therapies in inflammatory bowel disease.
Academic Article Safety and tolerability of concurrent natalizumab treatment for patients with Crohn's disease not in remission while receiving infliximab.
Academic Article Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trial.
Academic Article Immunosuppressive therapy in the formation of antibodies to infliximab in Crohn's disease.
Academic Article The effects of infliximab therapy on health-related quality of life in ulcerative colitis patients.
Academic Article Refining the role of TNF antagonists for Crohn's disease. Introduction.
Academic Article Controversies with aminosalicylates in inflammatory bowel disease.
Academic Article Infliximab: lifetime use for maintenance is appropriate in Crohn's Disease. A BALANCING VIEW: lifetime channeling of infliximab for crohn's disease.
Academic Article Reinduction with certolizumab pegol in patients with relapsed Crohn's disease: results from the PRECiSE 4 Study.
Academic Article Factors associated with the development of intestinal strictures or obstructions in patients with Crohn's disease.
Academic Article General principles and pharmacology of biologics in inflammatory bowel disease.
Academic Article Open-label study of adalimumab in patients with ulcerative colitis including those with prior loss of response or intolerance to infliximab.
Academic Article Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease.
Academic Article Continuous therapy with certolizumab pegol maintains remission of patients with Crohn's disease for up to 18 months.
Academic Article Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial.
Academic Article Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trial.
Academic Article Maintenance therapy with certolizumab pegol for Crohn's disease.
Academic Article Risks and benefits of combining immunosuppressives and biological agents in inflammatory bowel disease: is the synergy worth the risk?
Academic Article Tumor-associated glycoprotein (TAG-72) expression in ulcerative colitis.
Academic Article Adalimumab sustains steroid-free remission after 3 years of therapy for Crohn's disease.
Academic Article A phase I study of visilizumab, a humanized anti-CD3 monoclonal antibody, in severe steroid-refractory ulcerative colitis.
Academic Article Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab.
Academic Article Treatment of inflammatory bowel disease: a review of medical therapy.
Academic Article Management of inflammatory bowel disease: past, present and future.
Academic Article Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis.
Academic Article Circulating lymphocyte subpopulations in Crohn's disease.
Academic Article Prospective randomized open-label multicenter phase I/II dose escalation trial of visilizumab (HuM291) in severe steroid-refractory ulcerative colitis.
Academic Article Infliximab for induction and maintenance therapy for ulcerative colitis.
Academic Article Practical application of anti-TNF therapy for luminal Crohn's disease.
Academic Article What to take from TREAT?
Academic Article The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response?
Academic Article Predictors of adalimumab dose escalation in patients with Crohn's disease at a tertiary referral center.
Academic Article Ustekinumab induction and maintenance therapy in refractory Crohn's disease.
Academic Article Conventional treatment in inflammatory bowel disease--recent trends. Immunosuppressants and biologic agents: should they or need they be used together? How to use immunosuppressive therapy better (and safer) tomorrow?
Academic Article pANCA and classification resistance in ulcerative colitis.
Academic Article Randomised clinical trial: certolizumab pegol for fistulas in Crohn's disease - subgroup results from a placebo-controlled study.
Academic Article Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial.
Academic Article Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis.
Academic Article Review article: safety of infliximab in clinical trials.
Academic Article A randomized, double-blind, placebo-controlled trial of CDP571, a humanized monoclonal antibody to tumour necrosis factor-alpha, in patients with corticosteroid-dependent Crohn's disease.
Academic Article Infliximab or cyclosporine for severe ulcerative colitis.
Academic Article Clinical trial: impact of prior infliximab therapy on the clinical response to certolizumab pegol maintenance therapy for Crohn's disease.
Academic Article Evaluation of a daily practice composite score for the assessment of Crohn's disease: the treatment impact of certolizumab pegol.
Academic Article Long-term infliximab maintenance therapy for ulcerative colitis: the ACT-1 and -2 extension studies.
Academic Article Natalizumab in Crohn's disease: results from a US tertiary inflammatory bowel disease center.
Academic Article Mucosal healing is associated with improved long-term outcome of maintenance therapy with natalizumab in Crohn's disease.
Academic Article Incidence and predictors of clinical response, re-induction dose, and maintenance dose escalation with certolizumab pegol in Crohn's disease.
Academic Article Vedolizumab as induction and maintenance therapy for ulcerative colitis.
Academic Article Vedolizumab as induction and maintenance therapy for Crohn's disease.
Academic Article Still in pursuit.
Academic Article Postinduction serum infliximab trough level and decrease of C-reactive protein level are associated with durable sustained response to infliximab: a retrospective analysis of the ACCENT I trial.
Academic Article Effects of vedolizumab induction therapy for patients with Crohn's disease in whom tumor necrosis factor antagonist treatment failed.
Academic Article Comment on 'anti-adhesion therapies and the rule of 3 for rare events'.
Academic Article Briakinumab for treatment of Crohn's disease: results of a randomized trial.
Academic Article Reinduction with Certolizumab Pegol in Patients with Crohn's Disease Experiencing Disease Exacerbation: 7-Year Data from the PRECiSE 4 Study.
Academic Article Pharmacokinetics and Exposure Response Relationships of Ustekinumab in Patients With Crohn's Disease.
Academic Article Long-term efficacy and safety of ustekinumab for Crohn's disease through the second year of therapy.
Academic Article Targeting Crohn's disease.
Academic Article Checkpoint Inhibitor-Induced Colitis.
Academic Article Safety and efficacy of BI 695501 versus adalimumab reference product in patients with advanced Crohn's disease (VOLTAIRE-CD): a multicentre, randomised, double-blind, phase 3 trial.
Academic Article Etrolizumab for maintenance therapy in patients with moderately to severely active ulcerative colitis (LAUREL): a randomised, placebo-controlled, double-blind, phase 3 study.
Academic Article Efficacy and safety of vedolizumab and infliximab treatment for immune-mediated diarrhea and colitis in patients with cancer: a two-center observational study.
Academic Article A randomised, double-blind, placebo-controlled study of the LAG-3-depleting monoclonal antibody GSK2831781 in patients with active ulcerative colitis.
Academic Article The importance of predicting patient responses to monoclonal antibodies for Crohn's disease.
Search Criteria
  • Antibodies